
Xiaoxi Li is the Group Leader of ModelTropic Lab (M&T Lab). He received his PhD and conducted postdoctoral training at the Center for Excellence in Molecular Cell Science (CEMCS), Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences.
He is currently an Associate Professor in the Department of Laboratory Medicine, Jiangsu University, and a Master’s Supervisor in Clinical Laboratory Diagnostics.
Lab homepage: www.ModelTropic-Lab.com
Previous Publications (PhD & Postdoctoral Work)
Li X, Zhang Y, Zheng L, Liu M, Chen CD, Jiang H. UTX is an escape from X-inactivation tumor-suppressor in B cell lymphoma. Nat Commun. 2018;9(1):2720. doi:10.1038/s41467-018-05084-w
Liu C, Ding H, Li X, et al. A DNA/HDAC dual-targeting drug CY190602 with significantly enhanced anticancer potency. EMBO Mol Med. 2015;7(4):438–449. doi:10.15252/emmm.201404580
Ding H, Zhao J, Zhang Y, et al. Systematic Analysis of Drug Vulnerabilities Conferred by Tumor Suppressor Loss. Cell Rep. 2019;27(11):3310–3324.e5. doi:10.1016/j.celrep.2019.05.043
Yang W, Pan W, Chen S, et al. Dynamic regulation of CD28 conformation and signaling by charged lipids and ions. Nat Struct Mol Biol. 2017;24(12):1081–1090. doi:10.1038/nsmb.3489
Associate professor
Supervisor of Master's Candidates
Alma Mater : CEMCS-SIBCB
Discipline:Clinical Laboratory Diagnostics
The Last Update Time : ..